Partners Group Holding’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-441
Closed -$277K 43
2019
Q4
$277K Buy
+441
New +$216K 0.03% 49

Other funds holding CDLX

Partners Group Holding's CDLX Position: Q1 2020 in Review

Partners Group Holding sold out of Cardlytics (CDLX) in Q1 2020, closing a stake of 441 shares — an estimated $277K sold.

Partners Group Holding first reported a position in CDLX in Q4 2019 and held it in 1 quarter. The position peaked at $277K in Q4 2019. 142 funds tracked by Wall St. Rank hold CDLX as of Q1 2020.

  • Partners Group Holding reported no remaining Cardlytics position as of Q1 2020 after selling out during the quarter.
  • Partners Group Holding sold 441 Cardlytics shares in Q1 2020, an estimated $277K.
  • Partners Group Holding first reported a position in Cardlytics in Q4 2019 and held it in 1 quarter.
  • Partners Group Holding's Cardlytics position peaked at $277K in Q4 2019.
  • 142 funds tracked by Wall St. Rank held Cardlytics as of Q1 2020.

Based on Partners Group Holding's 13F filing for Q1 2020, filed 13 May 2020.